Stock SWAV SHOCKWAVE MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Shockwave Medical, Inc.

Equities

SWAV

US82489T1043

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
334.6 USD +0.12% Intraday chart for Shockwave Medical, Inc. +1.42% +75.56%
May. 16 Johnson & Johnson to Buy Proteologix For $850 Million in Cash MT
May. 13 Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Johnson & Johnson to Buy Proteologix For $850 Million in Cash
MT
Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition
MT
SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV
BU
Shockwave Medical: Q1 Earnings Snapshot
AQ
Shockwave Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shockwave Medical Reports First Quarter 2024 Financial Results
GL
Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024
CI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGBA, HIBB, SWAV
PR
Health Care Slips on Risk Bias -- Health Care Roundup
DJ
SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical to Johnson & Johnson
AQ
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Shockwave Medical, Inc. - SWAV
PR
CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368
MT
SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV
BU
Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study
GL
Shockwave Medical, Inc. Announces Investigators Presented Six-Month Data from the Full Population of the Reducer-I Study
CI
Leerink Partners Downgrades ShockWave Medical to Market Perform From Outperform, Cuts Price Target to $335 From $361
MT
Deutsche Bank Downgrades ShockWave Medical to Hold From Buy, Raises Price Target to $335 From $270
MT
Morgan Stanley Downgrades ShockWave Medical to Equal Weight From Overweight, Raises Price Target to $335 From $285
MT
Johnson & Johnson to Acquire Shockwave Medical
AQ
North American Morning Briefing : Inflation Data, -2-
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SWAV Stock
  4. News Shockwave Medical, Inc.